NCT02804217
Unknown
Not Applicable
Identification of Genomic Mutation Profile Using Next Generation Sequencing for Non-small-cell Lung Cancer Patients With Activating EGFR Mutations Harboring Acquired Resistance to the First-generation EGFR TKIs.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-small Cell Lung Cancer
- Sponsor
- Zhejiang Cancer Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- mutation profile
- Last Updated
- 9 years ago
Overview
Brief Summary
Patients with advanced non-small-cell lung cancer (NSCLC) harboring sensitive epithelial growth factor receptor (EGFR) mutations invariably develop acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). Identification of actionable genetic mutations can be helpful for guiding the subsequent treatment. This study aimed to analyze the genetic profile of NSCLC harboring acquired resistance to the first-generation EGFR TKIs using next generation sequencing (NGS).
Investigators
Yu Xinmin
Director
Zhejiang Cancer Hospital
Eligibility Criteria
Inclusion Criteria
- •Histologically proven stage IIIB or IV non-small cell lung cancer
- •patients harboring sensitive EGFR mutations and received first-generation EGFR-TKIs who developed acquired drug resistance
- •patients who can provide pre-treatment (EGFR TKIs) tumor tissues
- •patients with tumor lesions to be re-biopsy after drug resistance
- •patients must sign an informed consent indicating that they are aware of the .investigational nature of the study in keeping with the policy of the hospital.
Exclusion Criteria
- •History of another malignancy except cured basal cell carcinoma of skin and cured carcinoma in-situ of uterine cervix
- •patients with other systemic diseases
Outcomes
Primary Outcomes
mutation profile
Time Frame: 10 days
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients TreatmentNon-small Cell Lung Cancer (NSCLC)EGFR-TKI Resistant MutationEGFR-TKI Sensitizing MutationGermline MutationsSomatic MutationNCT01994057Sun Yat-sen University1,000
Unknown
Not Applicable
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation StatusNSCLCNCT01100827National University Hospital, Singapore
Unknown
Not Applicable
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia ChinaNonsmall Cell Lung CancerAdenocarcinomaNCT02980536Berry Genomics Co., Ltd.129
Unknown
Not Applicable
Gene Mutations in Non-Small Cell Lung Cancer CellsCarcinoma, Non-Small-Cell LungNCT00977509National Taiwan University Hospital200
Unknown
Not Applicable
The Tracking Molecular Evolution for NSCLC (T-MENC) StudyLung NeoplasmsLung CancerNonsmall Cell Lung CancerAdenocarcinoma of LungNCT03838588Geneplus-Beijing Co. Ltd.200